---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-006423"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-25T22:58:06.782586+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech raises $11M in registered direct offering; warrants could add $11M

## Summary
- Gross proceeds of ~$11M upfront from sale of 7.33M shares and warrants; warrants exercisable at $1.50/share for 5 years.
- Up to an additional $11M if all warrants are exercised for cash.
- Directors participated at $1.66/unit; institutional investors at $1.50/unit.
- Net proceeds ~$10.05M intended for R&D and general corporate purposes.
- Closing expected Feb 28, 2025; insiders subject to 60-day lock-up.

## SEC filing metadata
- accession: 0001140361-25-006423
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036125006423/0001140361-25-006423-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036125006423/ny20044490x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-006423
- JSON: https://secwatch.observer/filing/0001140361-25-006423.json
- Plain text: https://secwatch.observer/filing/0001140361-25-006423.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.